In brief, this study demonstrated that MAFF, ZFP36L1, and ADCYAP1 refer to diagnostic markers of AD, which may play central roles in disease initiation and progression and are thus promising molecular targets for diagnosis and treatment. Here, ADCYAP1 is linked to Alzheimer disease.